ABL Bio Financials
| 298380 Stock | KRW 27,050 600.00 2.17% |
ABL |
Understanding current and past ABL Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ABL Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in ABL Bio's assets may result in an increase in income on the income statement.
Please note, the presentation of ABL Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABL Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ABL Bio's management manipulating its earnings.
ABL Bio Stock Summary
ABL Bio competes with Genexine. ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7298380007 |
| Business Address | 16 Daewangpangyo-Ro 712 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.ablbio.com |
| Phone | 82 31 8018 9800 |
| Currency | KRW - South Korean Won |
You should never invest in ABL Bio without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ABL Stock, because this is throwing your money away. Analyzing the key information contained in ABL Bio's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
ABL Bio Key Financial Ratios
ABL Bio's financial ratios allow both analysts and investors to convert raw data from ABL Bio's financial statements into concise, actionable information that can be used to evaluate the performance of ABL Bio over time and compare it to other companies across industries.ABL Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ABL Bio's current stock value. Our valuation model uses many indicators to compare ABL Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABL Bio competition to find correlations between indicators driving ABL Bio's intrinsic value. More Info.ABL Bio is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value ABL Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ABL Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.ABL Bio Systematic Risk
ABL Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ABL Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on ABL Bio correlated with the market. If Beta is less than 0 ABL Bio generally moves in the opposite direction as compared to the market. If ABL Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ABL Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ABL Bio is generally in the same direction as the market. If Beta > 1 ABL Bio moves generally in the same direction as, but more than the movement of the benchmark.
ABL Bio November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ABL Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ABL Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of ABL Bio based on widely used predictive technical indicators. In general, we focus on analyzing ABL Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ABL Bio's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 26.64 | |||
| Value At Risk | (6.19) | |||
| Potential Upside | 6.6 |
Complementary Tools for ABL Stock analysis
When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges |